Filing Details
- Accession Number:
- 0001209191-20-007942
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-10 16:42:30
- Reporting Period:
- 2020-02-06
- Accepted Time:
- 2020-02-10 16:42:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 462702363 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1757799 | Calvin Yu | C/O Alector, Inc. 131 Oyster Point Blvd, Suite 600 South San Francisco CA 94080 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-06 | 1,096 | $8.16 | 126,390 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-06 | 725 | $10.14 | 127,115 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-06 | 2,621 | $35.00 | 124,494 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-07 | 2,825 | $8.16 | 127,319 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-02-07 | 7,400 | $10.14 | 134,719 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-07 | 24,033 | $35.02 | 110,686 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-02-06 | 1,096 | $0.00 | 1,096 | $8.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-02-06 | 725 | $0.00 | 725 | $10.14 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-02-07 | 2,825 | $0.00 | 2,825 | $8.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-02-07 | 7,400 | $0.00 | 7,400 | $10.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,363 | 2028-07-01 | No | 4 | M | Direct | |
| 29,275 | 2028-11-05 | No | 4 | M | Direct | |
| 32,538 | 2028-07-01 | No | 4 | M | Direct | |
| 21,875 | 2028-11-05 | No | 4 | M | Direct |
Footnotes
- The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $35.00 to $35.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and an additional one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- One fourth (1/4th) of the shares subject to the option vested on November 1, 2019, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Billionaire Hedge Funds
